Protalex Inc.

Protalex Inc.
Stock Exchange Other OTC
EPS
$0.13
Market Cap
$1.54 M
Shares Outstanding
47.33 M
Public Float
6.15 M

Profile

Address
131 Columbia Turnpike
Florham Park New Jersey 07932
United States
Employees -
Website http://www.protalex.com
Updated 07/08/2019
Protalex, Inc. is a development stage company which focuses on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis. Its product includes PRTX-100, formulated with purified staphylococcal protein A, which is an immune modulating protein produced by bacteria. The company was founded by John E.

Financials

View All
Created with Highcharts 5.0.14Protalex Inc.Net Income. Fiscal year is June-May. All values USD Thousands.6 2806 28011 85211 85211 61911 6199 4159 4154 5634 5635 0365 03620132014201520162017201802.5k5k7.5k10k12.5k

Arnold P. Kling
President & Director
Kirk M. Warshaw
Chief Financial Officer, Secretary & Director